Brandon Mysliwiec Contact
PrecisePepResearch Library

Research information only. PrecisePep is an educational library. It is not medical advice and is not intended to assist, encourage or enable self-administration. The compounds documented here are research chemicals — most are not approved for human use. Read the full disclaimer.

Prime Edge Training · Research Library

Peptide science,sorted by evidence.

Peptide Education for Researchers. 50 individual compounds and 9 blends, each documented across benefits, adverse effects, dosing, synergy and protocols — with what the literature reports, what mechanism predicts, and what the grey market claims kept rigorously apart.

50 peptides 9 blends & stacks 3 evidence tiers Full source links Research use only

The method

Three tiers. Never mixed.

Most peptide information fails in one specific way: it presents a rodent study, a mechanistic guess and a forum post as though they carry the same weight. Every section of every page on this site is split into three tiers, and each is labelled for what it is.

Highest confidence

Study-Reported

Reported in peer-reviewed literature, registered clinical trials, or regulatory filings. Note the model: much peptide literature is in vitro or rodent work, not human trial data.

Unproven — inference only

Theorized / Mechanistic

Extrapolated from a known mechanism, receptor profile, or adjacent compound class. Biologically plausible but not directly demonstrated for this compound in this context.

Uncontrolled reports

Grey Market & Community-Reported

Aggregated from research-community logs, forums, vendor literature and self-reported experience. Uncontrolled, unverified, subject to placebo, polypharmacy and product-purity confounds. Lowest evidentiary weight.

Why include the grey-market tier at all?

Because pretending it does not exist has never stopped anyone. The research community has practices, doses and protocols that differ substantially from published literature, and documenting them alongside the evidence — clearly labelled as uncontrolled self-report — is what lets a reader see the gap. Hiding them just means the only place to find them is somewhere with no caveats attached.

Monographs

What is on every page

Mechanism

Receptor targets and molecular pathways in plain language, with the parts that are inferred marked as inferred.

Benefits & adverse effects

Both split across all three tiers, with the study model stated on every entry — human trial, rodent, or cell culture.

Dosing

Published trial doses and community ranges in separate tables, so the distance between them is visible rather than blurred.

Synergy & protocols

Combination logic with links to every compound involved, and full protocols reproduced with annotation.

Handling & storage

Reconstitution, vial sizes, stability, and a direct link into the calculator preloaded for that compound.

Legal & anti-doping

Regulatory status and WADA position, stated on every page rather than buried in a footer.

Sources

Every reference links out to PubMed, a trial registry, or a primary regulatory document.

Evidence gaps

Where nothing has been studied, the page says so explicitly instead of leaving the section empty.

Library

Start anywhere

Six of the 50 compound monographs. Press / anywhere on the site to search.

Metabolic & Adipose Regulation

Retatrutide

LY3437943 · Reta

An investigational once-weekly triple agonist at the GLP-1, GIP and glucagon receptors — currently the most weight-effective single molecule in published obesity …

GLP-1GIPGlucagon Open monograph →
Regenerative & Tissue Repair

BPC-157

Body Protection Compound-157 · PL 14736

A 15-amino-acid fragment of a gastric protective protein with an unusually broad pre-clinical healing literature — and an unusually thin human one. The gap betwee…

AngiogenesisVEGFR2Tendon Open monograph →
Growth Hormone & Anabolic Support

Tesamorelin

TH9507 · Egrifta®

A stabilised growth-hormone-releasing hormone analogue and the only FDA-approved drug that specifically targets visceral adipose tissue — approved for one narrow …

GHRH analogueVisceral fatFDA approved Open monograph →
Mitochondrial & Bioenergetic

SS-31

Elamipretide · MTP-131

A cardiolipin-binding tetrapeptide that concentrates thousands-fold inside mitochondria and restores cristae architecture — the most clinically advanced mitochond…

CardiolipinCristaeATP Open monograph →
Neuro-Cognitive & Nootropic

Semax

Met-Glu-His-Phe-Pro-Gly-Pro · ACTH(4-7)-PGP

A Russian ACTH(4-7) analogue stripped of hormonal activity and registered in Russia as a nootropic and stroke medicine — with a large Russian-language clinical li…

BDNFNootropicIntranasal Open monograph →
Regenerative & Tissue Repair

GHK-Cu

Glycyl-L-histidyl-L-lysine copper(II) · copper peptide

An endogenous copper-binding tripeptide with a real human topical evidence base, a large gene-expression literature, and one property no other repair peptide has:…

CollagenECM remodellingCopper Open monograph →
All 50 peptides → All 9 blends →

Tool

Dosage & reconstitution calculator

Vial strength, diluent volume and target dose in; concentration, draw volume, syringe units, doses per vial and days of supply out — with a live syringe read-out, blend component breakdown, and a full sterile reconstitution guide.

Open the calculator →

Reference

Protocols, annotated

The Gold Standard Protocol — thirteen compounds across five pillars — and the fifteen-compound orchestration matrix, reproduced in full — with an assessment of where the reasoning holds, where it does not, and what monitoring they leave out.

Read the protocols →

Before anything else

This is a library, not a protocol

For educational and research reference only. Nothing on this site is medical advice, a recommendation, or an instruction to administer any substance to a human being. Most compounds documented here are not approved for human use anywhere in the world.

Read the full disclaimer →